Fideuram - Intesa Sanpaolo Private Banking’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fideuram - Intesa Sanpaolo Private Banking's BMY Position: Q2 2026 in Review
Fideuram - Intesa Sanpaolo Private Banking reduced its Bristol-Myers Squibb (BMY) stake by 44% in Q2 2026, selling an estimated $2.59M and leaving 57,474 shares worth $3.31M. The position accounts for 0.1% of the portfolio, ranked #185.
Fideuram - Intesa Sanpaolo Private Banking first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.22M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fideuram - Intesa Sanpaolo Private Banking held 57,474 shares of Bristol-Myers Squibb worth $3.31M as of Q2 2026.
- Fideuram - Intesa Sanpaolo Private Banking sold 45,097 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.59M.
- Bristol-Myers Squibb made up 0.1% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #185 holding.
- Fideuram - Intesa Sanpaolo Private Banking first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Fideuram - Intesa Sanpaolo Private Banking's Bristol-Myers Squibb position peaked at $6.22M in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.